Abstract
BAD (BCL-2 antagonist of cell death) is a proapoptotic BCL-2 family protein that plays a critical role in the regulation of apoptotic response. This study presents direct evidence that AF1q increased the radiation-induced apoptosis through up-regulation of BAD in human squamous carcinoma A431 cells and the key transcription factor involved is NF-κB. The minimal promoter sequence of BAD was identified; the activity was increased in AF1q stable transfectants and decreased upon AF1q siRNA transfection. The NF-κB consensus binding sequence is detected on BAD promoter. Inactivation of NF-κB by NF-κB inhibitor Bay 11-7082 or NF-κB p65 siRNA suppressed the expression and promoter activity of BAD; the suppression is more obvious in AF1q stable transfectants which also have an elevated NF-κB level. Mutation of putative NF-κB motif decreased the BAD promoter activity. The binding of NF-κB to the BAD promoter was confirmed by chromatinimmunoprecipitation. These findings indicate that AF1q upregulation of BAD is through its effect on NF-κB and this may hint of its oncogenic mechanism in cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 547-554 |
Number of pages | 8 |
Journal | Oncology reports |
Volume | 24 |
Issue number | 2 |
DOIs | |
State | Published - Aug 2010 |
Keywords
- Apoptosis
- NF-κB
- Squamous carcinoma
- γ irradiation
ASJC Scopus subject areas
- Oncology
- Cancer Research